The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Psychoneuroimmunological approach to gastrointestinal related pain
Scand J Pain
October 2017
https://pubmed.ncbi.nlm.nih.gov/29122501/
Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
J Transl Med
09 March 2018
https://pubmed.ncbi.nlm.nih.gov/29523156/
Low dose naltrexone for induction of remission in Crohn's disease
Cochrane Database Syst Rev
01 April 2018
https://pubmed.ncbi.nlm.nih.gov/29607497/
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Int J Pharm Compd
Mar-Apr 2010
https://mail.google.com/mail/u/0?ui=2&ik=b5d7923c33&attid=0.2&permmsgid=msg-f:1668161843235939361&th=1726805badf06421&view=att&disp=safe
The Benefits of Low Dose Naltrexone
JewishLink
21 May 2020
https://jewishlink.news/monthly-sections/health-link-new/37942-the-benefits-of-low-dose-naltrexone
Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study
Dig Dis Sci
November 2006
https://pubmed.ncbi.nlm.nih.gov/17080248/
Leonard Weinstock, MD - Celiac Disease (2017 Conference) (LDN, low dose naltrexone)
Celiac disease is a remarkable condition. It can present in so many different ways and have so many symptoms. What we're going to try is to hone down on the autoimmune conditions that are associated with it, which don't get as much attention in the literature as they should.
Nasha Winters, ND - Navigating the Narrative (2017 Conference) (LDN, low dose naltrexone)
Dr Nasha Winters speaks from experience when she talks about Cancer and how to be proactive in preventing and/or combating it. In her youth she was diagnosed with a terminal Cancer, but discovered the life changes that would turn it around.
Leonard Weinstock, MD - Inflammatory Bowel Disease II (2017 Conference) (LDN, low dose naltrexone)
Inflammatory bowel disease is a condition that we see as gastroenterologists on a daily basis. I'm Dr. Weinstock. I'd like to review inflammatory bowel disease, what the traditional approaches are, and some of the newer changes that we've seen with low dose naltrexone. Here are my disclosures.